Does the media prefer LFVN or PRE?

In the previous week, Lifevantage and Lifevantage both had 3 articles in the media. Prenetics Global's average media sentiment score of 0.80 beat Lifevantage's score of 0.64 indicating that Prenetics Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifevantage 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Prenetics Global 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate LFVN or YSG?

Lifevantage presently has a consensus price target of $5.00, suggesting a potential downside of 26.04%. Given Lifevantage's stronger consensus rating and higher possible upside, analysts plainly believe Lifevantage is more favorable than Yatsen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifevantage 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Yatsen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, LFVN or YSG?

Lifevantage has higher earnings, but lower revenue than Yatsen. Yatsen is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lifevantage $228.53M 0.37 $9.81M $0.45 15.02 Yatsen $614.62M 0.52 -$11.56M -$0.21 N/A

Is LFVN or YSG more profitable?

Lifevantage has a net margin of 2.94% compared to Yatsen's net margin of -3.04%. Lifevantage's return on equity of 23.89% beat Yatsen's return on equity. Company Net Margins Return on Equity Return on Assets Lifevantage 2.94% 23.89% 12.47% Yatsen -3.04% -4.54% -3.49%

Does the media prefer LFVN or NAGE?

In the previous week, Niagen Bioscience had 21 more articles in the media than Lifevantage. MarketBeat recorded 24 mentions for Niagen Bioscience and 3 mentions for Lifevantage. Lifevantage's average media sentiment score of 0.64 beat Niagen Bioscience's score of -0.01 indicating that Lifevantage is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifevantage 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Niagen Bioscience 4 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend NUS or LFVN?

Lifevantage has a consensus price target of $5.00, suggesting a potential downside of 26.04%. Given Lifevantage's stronger consensus rating and higher probable upside, analysts plainly believe Lifevantage is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nu Skin Enterprises 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Lifevantage 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor NUS or LFVN?

In the previous week, Lifevantage had 1 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 3 mentions for Lifevantage and 2 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 0.88 beat Lifevantage's score of 0.64 indicating that Nu Skin Enterprises is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nu Skin Enterprises 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lifevantage 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, WALD or LFVN?

Lifevantage has lower revenue, but higher earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waldencast $272.07M 0.66 -$229.75M N/A N/A Lifevantage $228.53M 0.37 $9.81M $0.45 15.02

Does the media prefer WALD or LFVN?

In the previous week, Lifevantage had 2 more articles in the media than Waldencast. MarketBeat recorded 3 mentions for Lifevantage and 1 mentions for Waldencast. Lifevantage's average media sentiment score of 0.64 beat Waldencast's score of 0.00 indicating that Lifevantage is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waldencast 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lifevantage 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Lifevantage (LFVN) Competitors

$6.76 0.00 (0.00%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$6.74 -0.01 (-0.22%)

As of 08/7/2026 07:34 PM Eastern

Compare

LFVN vs. PRE, YSG, NAGE, NUS, and WALD

Should you buy Lifevantage stock or one of its competitors? MarketBeat compares Lifevantage with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Lifevantage include Prenetics Global (PRE), Yatsen (YSG), Niagen Bioscience (NAGE), Nu Skin Enterprises (NUS), and Waldencast (WALD). These companies are all part of the "personal care products" industry.

How does Lifevantage compare to Prenetics Global?

Lifevantage (NASDAQ:LFVN) and Prenetics Global (NASDAQ:PRE) are both small-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

Lifevantage has a net margin of 2.94% compared to Prenetics Global's net margin of -62.45%. Lifevantage's return on equity of 23.89% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifevantage	2.94%	23.89%	12.47%
Prenetics Global	-62.45%	-20.33%	-15.42%

Lifevantage currently has a consensus price target of $5.00, indicating a potential downside of 26.04%. Prenetics Global has a consensus price target of $34.25, indicating a potential upside of 87.57%. Given Prenetics Global's stronger consensus rating and higher possible upside, analysts plainly believe Prenetics Global is more favorable than Lifevantage.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifevantage	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

In the previous week, Lifevantage and Lifevantage both had 3 articles in the media. Prenetics Global's average media sentiment score of 0.80 beat Lifevantage's score of 0.64 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lifevantage	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prenetics Global	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lifevantage has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.26, suggesting that its share price is 74% less volatile than the broader market.

Lifevantage has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifevantage	$228.53M	0.37	$9.81M	$0.45	15.02
Prenetics Global	$92.39M	3.33	-$37.71M	-$4.58	N/A

35.3% of Lifevantage shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 22.0% of Lifevantage shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Lifevantage beats Prenetics Global on 10 of the 15 factors compared between the two stocks.

How does Lifevantage compare to Yatsen?

Lifevantage (NASDAQ:LFVN) and Yatsen (NYSE:YSG) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Lifevantage has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market. Comparatively, Yatsen has a beta of -1.55, meaning that its share price is 255% less volatile than the broader market.

Lifevantage presently has a consensus price target of $5.00, suggesting a potential downside of 26.04%. Given Lifevantage's stronger consensus rating and higher possible upside, analysts plainly believe Lifevantage is more favorable than Yatsen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifevantage	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Yatsen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Lifevantage has higher earnings, but lower revenue than Yatsen. Yatsen is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifevantage	$228.53M	0.37	$9.81M	$0.45	15.02
Yatsen	$614.62M	0.52	-$11.56M	-$0.21	N/A

Lifevantage has a net margin of 2.94% compared to Yatsen's net margin of -3.04%. Lifevantage's return on equity of 23.89% beat Yatsen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifevantage	2.94%	23.89%	12.47%
Yatsen	-3.04%	-4.54%	-3.49%

In the previous week, Lifevantage had 3 more articles in the media than Yatsen. MarketBeat recorded 3 mentions for Lifevantage and 0 mentions for Yatsen. Lifevantage's average media sentiment score of 0.64 beat Yatsen's score of 0.00 indicating that Lifevantage is being referred to more favorably in the media.

Company	Overall Sentiment
Lifevantage	Positive
Yatsen	Neutral

35.3% of Lifevantage shares are owned by institutional investors. 22.0% of Lifevantage shares are owned by company insiders. Comparatively, 29.0% of Yatsen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Lifevantage beats Yatsen on 12 of the 15 factors compared between the two stocks.

How does Lifevantage compare to Niagen Bioscience?

Lifevantage (NASDAQ:LFVN) and Niagen Bioscience (NASDAQ:NAGE) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

Lifevantage currently has a consensus target price of $5.00, suggesting a potential downside of 26.04%. Niagen Bioscience has a consensus target price of $10.33, suggesting a potential upside of 231.20%. Given Niagen Bioscience's stronger consensus rating and higher probable upside, analysts clearly believe Niagen Bioscience is more favorable than Lifevantage.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifevantage	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Niagen Bioscience	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

Lifevantage has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market. Comparatively, Niagen Bioscience has a beta of 2.09, indicating that its stock price is 109% more volatile than the broader market.

35.3% of Lifevantage shares are owned by institutional investors. Comparatively, 15.4% of Niagen Bioscience shares are owned by institutional investors. 22.0% of Lifevantage shares are owned by company insiders. Comparatively, 10.0% of Niagen Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Niagen Bioscience has lower revenue, but higher earnings than Lifevantage. Lifevantage is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifevantage	$228.53M	0.37	$9.81M	$0.45	15.02
Niagen Bioscience	$129.42M	1.92	$17.38M	$0.18	17.33

Niagen Bioscience has a net margin of 12.39% compared to Lifevantage's net margin of 2.94%. Lifevantage's return on equity of 23.89% beat Niagen Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifevantage	2.94%	23.89%	12.47%
Niagen Bioscience	12.39%	17.95%	13.17%

In the previous week, Niagen Bioscience had 21 more articles in the media than Lifevantage. MarketBeat recorded 24 mentions for Niagen Bioscience and 3 mentions for Lifevantage. Lifevantage's average media sentiment score of 0.64 beat Niagen Bioscience's score of -0.01 indicating that Lifevantage is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lifevantage	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Niagen Bioscience	4 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Niagen Bioscience beats Lifevantage on 11 of the 17 factors compared between the two stocks.

How does Lifevantage compare to Nu Skin Enterprises?

Nu Skin Enterprises (NYSE:NUS) and Lifevantage (NASDAQ:LFVN) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

82.8% of Nu Skin Enterprises shares are held by institutional investors. Comparatively, 35.3% of Lifevantage shares are held by institutional investors. 2.8% of Nu Skin Enterprises shares are held by company insiders. Comparatively, 22.0% of Lifevantage shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Nu Skin Enterprises has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market. Comparatively, Lifevantage has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market.

Lifevantage has a consensus price target of $5.00, suggesting a potential downside of 26.04%. Given Lifevantage's stronger consensus rating and higher probable upside, analysts plainly believe Lifevantage is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Lifevantage	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Nu Skin Enterprises has a net margin of 3.78% compared to Lifevantage's net margin of 2.94%. Lifevantage's return on equity of 23.89% beat Nu Skin Enterprises' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
Lifevantage	2.94%	23.89%	12.47%

In the previous week, Lifevantage had 1 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 3 mentions for Lifevantage and 2 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 0.88 beat Lifevantage's score of 0.64 indicating that Nu Skin Enterprises is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nu Skin Enterprises	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lifevantage	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nu Skin Enterprises pays an annual dividend of $0.24 per share and has a dividend yield of 4.4%. Lifevantage pays an annual dividend of $0.20 per share and has a dividend yield of 3.0%. Nu Skin Enterprises pays out 21.8% of its earnings in the form of a dividend. Lifevantage pays out 44.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Lifevantage has increased its dividend for 3 consecutive years. Nu Skin Enterprises is clearly the better dividend stock, given its higher yield and lower payout ratio.

Nu Skin Enterprises has higher revenue and earnings than Lifevantage. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.49B	0.18	$160.20M	$1.10	5.00
Lifevantage	$228.53M	0.37	$9.81M	$0.45	15.02

Summary

Nu Skin Enterprises and Lifevantage tied by winning 9 of the 18 factors compared between the two stocks.

How does Lifevantage compare to Waldencast?

Waldencast (NASDAQ:WALD) and Lifevantage (NASDAQ:LFVN) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.

Waldencast has a beta of -0.13, indicating that its share price is 113% less volatile than the broader market. Comparatively, Lifevantage has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market.

Waldencast currently has a consensus target price of $2.33, suggesting a potential upside of 67.87%. Lifevantage has a consensus target price of $5.00, suggesting a potential downside of 26.04%. Given Waldencast's stronger consensus rating and higher possible upside, equities research analysts plainly believe Waldencast is more favorable than Lifevantage.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Lifevantage	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Lifevantage has lower revenue, but higher earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waldencast	$272.07M	0.66	-$229.75M	N/A	N/A
Lifevantage	$228.53M	0.37	$9.81M	$0.45	15.02

42.0% of Waldencast shares are owned by institutional investors. Comparatively, 35.3% of Lifevantage shares are owned by institutional investors. 22.0% of Lifevantage shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Lifevantage had 2 more articles in the media than Waldencast. MarketBeat recorded 3 mentions for Lifevantage and 1 mentions for Waldencast. Lifevantage's average media sentiment score of 0.64 beat Waldencast's score of 0.00 indicating that Lifevantage is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waldencast	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lifevantage	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lifevantage has a net margin of 2.94% compared to Waldencast's net margin of 0.00%. Lifevantage's return on equity of 23.89% beat Waldencast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waldencast	N/A	N/A	N/A
Lifevantage	2.94%	23.89%	12.47%

Summary

Lifevantage beats Waldencast on 8 of the 14 factors compared between the two stocks.

Get Lifevantage News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFVN vs. The Competition

Export

Metric	Lifevantage	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$85.31M	$22.85B	$16.26B	$12.99B
Dividend Yield	2.96%	4.27%	3.20%	10.20%
P/E Ratio	15.02	15.79	14.13	25.05
Price / Sales	0.37	12.93	264,297.19	84.15
Price / Cash	6.15	17.43	56.22	37.44
Price / Book	2.46	3.01	4.99	6.43
Net Income	$9.81M	$1.08B	$838.30M	$348.10M
7 Day Performance	2.74%	2.35%	0.39%	2.68%
1 Month Performance	8.33%	-1.28%	0.34%	-0.83%
1 Year Performance	-49.17%	-17.02%	13.16%	23.97%

Lifevantage Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFVN Lifevantage	2.0375 of 5 stars	$6.76 flat	$5.00 -26.0%	-49.2%	$85.31M	$228.53M	15.02	260	Gap Down
PRE Prenetics Global	2.5765 of 5 stars	$18.57 +0.3%	$34.25 +84.4%	+146.1%	$311.51M	$92.39M	N/A	1	Gap Down
YSG Yatsen	0.4409 of 5 stars	$3.10 -5.2%	N/A	-62.8%	$290.91M	$614.62M	N/A	1,623	Gap Down
NAGE Niagen Bioscience	3.2098 of 5 stars	$3.59 +1.6%	$10.50 +192.9%	-67.9%	$285.51M	$129.42M	17.07	120	Trending News Earnings Report Analyst Revision
NUS Nu Skin Enterprises	2.3868 of 5 stars	$5.34 +3.4%	N/A	-38.3%	$259.01M	$1.49B	4.85	2,800	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFVN) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lifevantage (LFVN) Competitors

LFVN vs. PRE, YSG, NAGE, NUS, and WALD

How does Lifevantage compare to Prenetics Global?

Summary

How does Lifevantage compare to Yatsen?

Summary

How does Lifevantage compare to Niagen Bioscience?

Summary

How does Lifevantage compare to Nu Skin Enterprises?

Summary

How does Lifevantage compare to Waldencast?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFVN vs. The Competition

Lifevantage Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lifevantage (LFVN) Competitors

LFVN vs. PRE, YSG, NAGE, NUS, and WALD

How does Lifevantage compare to Prenetics Global?

Is LFVN or PRE more profitable?

Do analysts recommend LFVN or PRE?

Does the media prefer LFVN or PRE?

Which has more risk and volatility, LFVN or PRE?

Which has higher earnings and valuation, LFVN or PRE?

Do institutionals & insiders believe in LFVN or PRE?

Summary

How does Lifevantage compare to Yatsen?

Which has more risk & volatility, LFVN or YSG?

Do analysts rate LFVN or YSG?

Which has stronger valuation & earnings, LFVN or YSG?

Is LFVN or YSG more profitable?

Does the media refer more to LFVN or YSG?

Do institutionals & insiders hold more shares of LFVN or YSG?

Summary

How does Lifevantage compare to Niagen Bioscience?

Do analysts recommend LFVN or NAGE?

Which has more volatility & risk, LFVN or NAGE?

Do institutionals and insiders hold more shares of LFVN or NAGE?

Which has better earnings and valuation, LFVN or NAGE?

Is LFVN or NAGE more profitable?

Does the media prefer LFVN or NAGE?

Summary

How does Lifevantage compare to Nu Skin Enterprises?

Do institutionals and insiders hold more shares of NUS or LFVN?

Which has more risk and volatility, NUS or LFVN?

Do analysts recommend NUS or LFVN?

Is NUS or LFVN more profitable?

Does the media favor NUS or LFVN?

Is NUS or LFVN a better dividend stock?

Which has better earnings and valuation, NUS or LFVN?

Summary

How does Lifevantage compare to Waldencast?

Which has more risk & volatility, WALD or LFVN?

Do analysts recommend WALD or LFVN?

Which has stronger earnings & valuation, WALD or LFVN?

Do insiders & institutionals hold more shares of WALD or LFVN?

Does the media prefer WALD or LFVN?

Is WALD or LFVN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFVN vs. The Competition

Lifevantage Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools